Catalyst Wire Dossier Catalyst Wire Dossier

OTX-TIC Travoprost Intracameral Implant

travoprost · Ocular Therapeutix, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OTX-TIC Travoprost Intracameral Implant, covering 2025-03-21 to 2025-03-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT) [Phase 2]

See pricing